Palatin Technologies
PTN
#10932
Rank
A$13.7 M
Marketcap
A$7.69
Share price
-3.72%
Change (1 day)
-60.76%
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$2.73 Million

According to Palatin Technologies's latest financial reports the company's total liabilities are A$2.73 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30A$12.22 M-24.81%
2024-06-30A$16.26 M-45.59%
2023-06-30A$29.88 M4.11%
2022-06-30A$28.7 M21.99%
2021-06-30A$23.53 M232.79%
2020-06-30A$7.07 M18.65%
2019-06-30A$5.95 M-63.39%
2018-06-30A$16.27 M-79.84%
2017-06-30A$80.75 M111.47%
2016-06-30A$38.18 M70.13%
2015-06-30A$22.44 M664.02%
2014-06-30A$2.93 M27.97%
2013-06-30A$2.29 M-33.76%
2012-06-30A$3.46 M24.6%
2011-06-30A$2.78 M-23.28%
2010-06-30A$3.62 M-70.34%
2009-06-30A$12.22 M-7.04%
2008-06-30A$13.14 M-54.1%
2007-06-30A$28.63 M-2.6%
2006-06-30A$29.4 M-13.52%
2005-06-30A$33.99 M179.06%
2004-06-30A$12.18 M100.17%
2003-06-30A$6.08 M-6.95%
2002-06-30A$6.54 M43.74%
2001-06-30A$4.55 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$172.47 B 6,307,542.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$97.42 B 3,562,725.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$2.47 B 90,544.88%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
A$4.7 M 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.81 B 66,209.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$1.33 B 48,713.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
A$3.89 M 42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.63 B 23,133.01%๐Ÿ‡บ๐Ÿ‡ธ USA